Swapnil Potdar - Publications

A host-centric morphological profiling approach to identify repurposed antiviral drugs.

Journal: iScience

Published: March 19, 2026

Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.

Journal: HemaSphere

Published: October 27, 2025

Drug sensitivity testing of patient-derived bone sarcomas identifies selective kinase inhibitors for patients with refractory disease.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: October 23, 2025

Spatial artifact detection improves the reproducibility of drug screening experiments.

Journal: iScience

Published: April 18, 2025

High-content Image-based Drug Testing of Patients' Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma.

Journal: Acta dermato-venereologica

Published: February 25, 2025

Computational drug repurposing: approaches, evaluation of in silico resources and case studies.

Journal: Nature reviews. Drug discovery

Published: February 19, 2025

Functional screening identifies kinesin spindle protein inhibitor filanesib as a potential treatment option for hepatoblastoma.

Journal: NPJ precision oncology

Published: August 06, 2024

Characterisation of new in vitro models and identification of potentially active drugs in angiosarcoma.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 28, 2023

Drug repurposing platform for deciphering the druggable SARS-CoV-2 interactome.

Journal: Antiviral research

Published: November 15, 2023

Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia.

Journal: Cell reports. Medicine

Published: September 20, 2023

Breeze 2.0: an interactive web-tool for visual analysis and comparison of drug response data.

Journal: Nucleic acids research

Published: March 26, 2023

Robust scoring of selective drug responses for patient-tailored therapy selection.

Journal: Nature protocols

Published: March 24, 2023